Director's Dealing • Apr 21, 2021
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2159W
Eco Animal Health Group PLC
21 April 2021
ECO Animal Health Group plc
(''ECO" or "the Company")
(AIM: EAH)
ECO Animal Health Group announces that Lloyd Smart, a PDMR, has sold 8,000 ordinary shares in the Company at a price of 360 pence per share on 20 April 2021 following an exercise of 8,000 options over ordinary shares under the Company's 2011 Unapproved Staff Share Option Scheme ("USOS").
Contacts:
| ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO) |
020 8447 8899 |
| IFC Advisory Graham Herring Zach Cohen |
020 3934 6630 |
| N+1 Singer (Nominated Adviser & Joint Broker) Mark Taylor Iqra Amin |
020 7496 3000 |
| Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden |
020 7418 8900 |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Lloyd Smart | |
| 2 | Reason for the notification | ||
| a) | Position/status | PDMR | |
| b) | Initial notification/Amendment | Initial Notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Eco Animal Health Group Plc | |
| b) | LEI | 2138009XN9DJ3YP70B55 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 5p each GB0032036807 |
|
| b) | Nature of transaction | Sale and Exercise of options | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 360p | 8000 | ||
| Aggregated information - Aggregated volume - Price |
8000 360p |
||
| e) | Date of the transaction | 20 April 2021 | |
| f) | Place of the transaction | AIM |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBUGDSBXDDGBB
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.